HYBIO PHARMACEUTICAL CO., LTD.
|
Eptifibatide is a platelet aggregation inhibitor primarily used in the treatment of acute coronary syndrome (ACS) and during percutaneous coronary intervention (PCI) to prevent cardiac ischemic complications. It works by blocking the platelet glycoprotein IIb/IIIa receptor, which is involved in the final pathway to platelet aggregation. |
Send Inquiry
|